Literature DB >> 35039657

Post-acute neurological consequences of COVID-19: an unequal burden.

LaShyra T Nolen1, Shibani S Mukerji1,2, Nicte I Mejia3,4.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35039657     DOI: 10.1038/s41591-021-01647-5

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  15 in total

1.  Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.

Authors:  Amy L Ross Russell; Marc Hardwick; Athavan Jeyanantham; Laura M White; Saumitro Deb; Girvan Burnside; Harriet M Joy; Craig J Smith; Thomas A Pollak; Timothy R Nicholson; Nicholas W S Davies; Hadi Manji; Ava Easton; Stephen Ray; Michael S Zandi; Jonathan P Coles; David K Menon; Aravinthan Varatharaj; Beth McCausland; Mark A Ellul; Naomi Thomas; Gerome Breen; Stephen Keddie; Michael P Lunn; John P S Burn; Graziella Quattrocchi; Luke Dixon; Claire M Rice; George Pengas; Rustam Al-Shahi Salman; Alan Carson; Eileen M Joyce; Martin R Turner; Laura A Benjamin; Tom Solomon; Rachel Kneen; Sarah Pett; Rhys H Thomas; Benedict D Michael; Ian Galea
Journal:  Brain Commun       Date:  2021-07-22

2.  Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.

Authors:  Sherry H-Y Chou; Ettore Beghi; Raimund Helbok; Elena Moro; Joshua Sampson; Valeria Altamirano; Shraddha Mainali; Claudio Bassetti; Jose I Suarez; Molly McNett
Journal:  JAMA Netw Open       Date:  2021-05-03

3.  Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 Pandemic.

Authors:  Adam de Havenon; John P Ney; Brian Callaghan; Samuel Hohmann; Ernie Shippey; Shadi Yaghi; Mohammad Anadani; Jennifer J Majersik
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 4.  Inequities in neurology amplified by the COVID-19 pandemic.

Authors:  LaShyra Nolen; Nicte I Mejia
Journal:  Nat Rev Neurol       Date:  2021-02       Impact factor: 42.937

5.  Experiences of Latinx Individuals Hospitalized for COVID-19: A Qualitative Study.

Authors:  Lilia Cervantes; Marlene Martin; Maria G Frank; Julia F Farfan; Mark Kearns; Luis A Rubio; Allison Tong; Andrea Matus Gonzalez; Claudia Camacho; Adriana Collings; William Mundo; Neil R Powe; Alicia Fernandez
Journal:  JAMA Netw Open       Date:  2021-03-01

6.  Evolving phenotypes of non-hospitalized patients that indicate long COVID.

Authors:  Hossein Estiri; Zachary H Strasser; Gabriel A Brat; Yevgeniy R Semenov; Chirag J Patel; Shawn N Murphy
Journal:  BMC Med       Date:  2021-09-27       Impact factor: 11.150

7.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

Authors:  Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami
Journal:  EClinicalMedicine       Date:  2021-07-15

8.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

9.  Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America.

Authors:  Adam A Dmytriw; Kevin Phan; Clemens Schirmer; Fabio Settecase; Manraj K S Heran; Aslan Efendizade; Anna Luisa Kühn; Ajit S Puri; Bijoy K Menon; Mahmoud Dibas; Sanjeev Sivakumar; Ashkan Mowla; Lester Y Leung; Adel M Malek; Barbara Voetsch; Siddharth Sehgal; Ajay K Wakhloo; Hannah Wu; Andrew Xavier; Ambooj Tiwari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-08-13       Impact factor: 10.154

View more
  13 in total

1.  Long-term neurologic outcomes of COVID-19.

Authors:  Evan Xu; Yan Xie; Ziyad Al-Aly
Journal:  Nat Med       Date:  2022-09-22       Impact factor: 87.241

Review 2.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

3.  Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors.

Authors:  Hamidreza Zalpoor; Hooriyeh Shapourian; Abdullatif Akbari; Shaghayegh Shahveh; Leila Haghshenas
Journal:  Hum Cell       Date:  2022-05-09       Impact factor: 4.374

Review 4.  COVID-19 2022 update: transition of the pandemic to the endemic phase.

Authors:  Michela Biancolella; Vito Luigi Colona; Giuseppe Novelli; Juergen K V Reichardt; Ruty Mehrian-Shai; Jessica Lee Watt; Lucio Luzzatto
Journal:  Hum Genomics       Date:  2022-06-01       Impact factor: 6.481

5.  Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID.

Authors:  Marko Ercegovac; Milika Asanin; Ana Savic-Radojevic; Jovan Ranin; Marija Matic; Tatjana Djukic; Vesna Coric; Djurdja Jerotic; Nevena Todorovic; Ivana Milosevic; Goran Stevanovic; Tatjana Simic; Zoran Bukumiric; Marija Pljesa-Ercegovac
Journal:  Antioxidants (Basel)       Date:  2022-05-12

Review 6.  SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.

Authors:  Jorge Quarleri; M Victoria Delpino
Journal:  Geroscience       Date:  2022-02-14       Impact factor: 7.713

Review 7.  Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.

Authors:  Bin Wang; Lei Zhang; Yongqiang Wang; Tong Dai; Ziran Qin; Fangfang Zhou; Long Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-04-29

8.  Novel 3-D action video game mechanics reveal differentiable cognitive constructs in young players, but not in old.

Authors:  Tomihiro Ono; Takeshi Sakurai; Shinichi Kasuno; Toshiya Murai
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996

9.  Perceived discrimination as a modifier of health, disease, and medicine: empirical data from the COVID-19 pandemic.

Authors:  Moriah E Thomason; Cassandra L Hendrix; Denise Werchan; Natalie H Brito
Journal:  Transl Psychiatry       Date:  2022-07-15       Impact factor: 7.989

10.  Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study.

Authors:  Reza Ramazani Khorshiddoust; Saleh Ramazani Khorshiddoust; Tahereh Hosseinabadi; Faezeh Mottaghitalab; Farzad Mokhtari; Fatemeh Azadinia; Hossein Mozdarani; Mohammad Shabani; Hamid Emadi-Kouchak; Bahram Taheri; Fatemeh Khani-Juyabad; Mina Amjadi Kashani; Arezoo Sadoughi; Sorour Zamanizadeh; Hadyeh Maddah; Maedeh Aminzadeh; Maryam Khanaki; Sabereh Saremi; Anahita Pashaee Rad; Ali Fatehi; Melika Ghaznavi Rad; Masoud Haftbaradaran; Mehran Khosroshahi; Mahtab Sadeghi; Majid Aminnayeri; Sirous Jafari; Fereshteh Ghiasvand; Arash Seifi; Sara Ghaderkhani; Seyed Ali Dehghan Manshadi; Mohammadreza Salehi; Ladan Abbasian; Malihe Hasannezhad; Mohsen Meidani; Mahboubeh Hajiabdolbaghi; Zahra Ahmadinejad; Masoud Parash; Zahra Sedighi; Abdorreza Mohammadian
Journal:  Biomed Pharmacother       Date:  2022-02-17       Impact factor: 7.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.